Cargando…

Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood

Background: Early drug intervention in childhood disorders aims to maximize individual potential in the short- and long-term. Consistently, juvenile exposure to psychostimulants, such as methylphenidate (MPH), reduces risk for substance use in animals and sub-populations of individuals with attentio...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Susan L., Sonntag, Kai C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896878/
https://www.ncbi.nlm.nih.gov/pubmed/24478696
http://dx.doi.org/10.3389/fnsyn.2014.00001
_version_ 1782300152570052608
author Andersen, Susan L.
Sonntag, Kai C.
author_facet Andersen, Susan L.
Sonntag, Kai C.
author_sort Andersen, Susan L.
collection PubMed
description Background: Early drug intervention in childhood disorders aims to maximize individual potential in the short- and long-term. Consistently, juvenile exposure to psychostimulants, such as methylphenidate (MPH), reduces risk for substance use in animals and sub-populations of individuals with attention deficit hyperactivity disorder (ADHD). We investigated the effects of MPH on brain plasticity via dopamine receptor D3 (D3R) and brain-derived neurotrophic factor (BDNF) expression in developing rats. Methods: Between postnatal days 20–35, rat pups were administered saline vehicle (Veh) or MPH (2 mg/kg), the D3R-preferring agonist ±7-OHDPAT, or the antagonist nafadotride (0.05 mg/kg) alone, or in combination with MPH twice a day. In adulthood, subjects were challenged to Veh or cocaine (10 mg/kg for two days). The prefrontal cortex was analyzed for protein and mRNA levels of total BDNF, its splice variants I, IIc, III/IV, and IV/VI, and D3 receptors. A separate group of subjects was assessed for splice variants at 20, 35, 40, and 60 days of age. Results: Across age strong correlations were evident between Drd3 and Bdnf mRNA levels (r = 0.65) and a negative relationship between Drd3 and exon IIc after MPH treatment (r = −0.73). BDNF protein levels did not differ between Veh- and MPH subjects at baseline, but were significantly lower in MPH-treated and cocaine challenged subjects (30.3 ± 9.7%). Bdnf mRNA was significantly higher in MPH-treated subjects, and reversed upon exposure to cocaine. This effect was blocked by nafadotride. Furthermore, Bdnf(total) and Bdnf splice variants I, IIc, III/IV, and IV/VI changed across the transitions between juvenility and late adolescence. Conclusions: These data suggest a sensitive window of vulnerability to modulation of BDNF expression around adolescence, and that compared to normal animals, juvenile exposure to MPH permanently reduces prefrontal BDNF transcription and translation upon cocaine exposure in adulthood by a D3R-mediated mechanism.
format Online
Article
Text
id pubmed-3896878
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-38968782014-01-29 Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood Andersen, Susan L. Sonntag, Kai C. Front Synaptic Neurosci Neuroscience Background: Early drug intervention in childhood disorders aims to maximize individual potential in the short- and long-term. Consistently, juvenile exposure to psychostimulants, such as methylphenidate (MPH), reduces risk for substance use in animals and sub-populations of individuals with attention deficit hyperactivity disorder (ADHD). We investigated the effects of MPH on brain plasticity via dopamine receptor D3 (D3R) and brain-derived neurotrophic factor (BDNF) expression in developing rats. Methods: Between postnatal days 20–35, rat pups were administered saline vehicle (Veh) or MPH (2 mg/kg), the D3R-preferring agonist ±7-OHDPAT, or the antagonist nafadotride (0.05 mg/kg) alone, or in combination with MPH twice a day. In adulthood, subjects were challenged to Veh or cocaine (10 mg/kg for two days). The prefrontal cortex was analyzed for protein and mRNA levels of total BDNF, its splice variants I, IIc, III/IV, and IV/VI, and D3 receptors. A separate group of subjects was assessed for splice variants at 20, 35, 40, and 60 days of age. Results: Across age strong correlations were evident between Drd3 and Bdnf mRNA levels (r = 0.65) and a negative relationship between Drd3 and exon IIc after MPH treatment (r = −0.73). BDNF protein levels did not differ between Veh- and MPH subjects at baseline, but were significantly lower in MPH-treated and cocaine challenged subjects (30.3 ± 9.7%). Bdnf mRNA was significantly higher in MPH-treated subjects, and reversed upon exposure to cocaine. This effect was blocked by nafadotride. Furthermore, Bdnf(total) and Bdnf splice variants I, IIc, III/IV, and IV/VI changed across the transitions between juvenility and late adolescence. Conclusions: These data suggest a sensitive window of vulnerability to modulation of BDNF expression around adolescence, and that compared to normal animals, juvenile exposure to MPH permanently reduces prefrontal BDNF transcription and translation upon cocaine exposure in adulthood by a D3R-mediated mechanism. Frontiers Media S.A. 2014-01-21 /pmc/articles/PMC3896878/ /pubmed/24478696 http://dx.doi.org/10.3389/fnsyn.2014.00001 Text en Copyright © 2014 Andersen and Sonntag. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Andersen, Susan L.
Sonntag, Kai C.
Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title_full Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title_fullStr Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title_full_unstemmed Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title_short Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
title_sort juvenile methylphenidate reduces prefrontal cortex plasticity via d3 receptor and bdnf in adulthood
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896878/
https://www.ncbi.nlm.nih.gov/pubmed/24478696
http://dx.doi.org/10.3389/fnsyn.2014.00001
work_keys_str_mv AT andersensusanl juvenilemethylphenidatereducesprefrontalcortexplasticityviad3receptorandbdnfinadulthood
AT sonntagkaic juvenilemethylphenidatereducesprefrontalcortexplasticityviad3receptorandbdnfinadulthood